Advertisement
Screener

MiniMed Group, Inc. (MMED) Overview

MiniMed Group, Inc. (MMED) Overview

  • 25 Apr 2026: Period ending 31 Jul 2026; Estimate (m); Actual 0.00; Beat / miss (m).
  • 25 Oct 2025: Period ending 23 Jan 2026; Estimate (m); Actual -0.47; Beat / miss (m).
  • 26 Apr 2025: Period ending 25 Jul 2025; Estimate (m); Actual -0.08; Beat / miss (m).
  • 26 Oct 2024: Period ending 24 Jan 2025; Estimate (m); Actual -0.04; Beat / miss (m).

Stock Price Chart

View more →

Blue: Split-adjusted close · Orange: Cumulative dividend-reinvested close

$10.26$12.26$14.66$17.52$20.94$25.032026-03-062026-11-06$10.26$12.26$14.66$17.52$20.94$25.032026-03-062026-11-06$10.26$12.26$14.66$17.52$20.94$25.032026-03-062026-11-06$10.26$12.26$14.66$17.52$20.94$25.032026-03-062026-11-06$10.26$12.26$14.66$17.52$20.94$25.032026-03-062026-11-06

Logarithmic scale. Both lines share the same starting value for the selected range.

Last close
$16.71
Previous close
$20.04
Change
-$3.33
Change (%)
-16.59%
Close date
2026-11-06
Previous close date
2026-09-29
Open
(m)
Day high
(m)
Day low
(m)
Last session volume
(m)
Last session value
(m)
Currency
USD
Price basis
split-adjusted
Volume basis
(m)

Performance

View more →

Cumulative total returns · 2026-09-29

YTD

MMED
(m)
S&P 500
(m)

1 year

MMED
(m)
S&P 500
(m)

3 years

MMED
(m)
S&P 500
(m)

5 years

MMED
(m)
S&P 500
(m)

Earnings trends

View more →

Earnings per share

USD / share · As filed

31 Jul 2026 ○ Estimate (m) ● Actual 0.00

-0.55-0.37-0.18-0.000.1824 Jan 2025: estimate (m); actual -0.0424 Jan 2025(m)25 Jul 2025: estimate (m); actual -0.0825 Jul 2025(m)23 Jan 2026: estimate (m); actual -0.4723 Jan 2026(m)31 Jul 2026: estimate (m); actual 0.0031 Jul 2026(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
25 Apr 202631 Jul 2026(m)0.00(m)(m)
25 Oct 202523 Jan 2026(m)-0.47(m)(m)
26 Apr 202525 Jul 2025(m)-0.08(m)(m)
26 Oct 202424 Jan 2025(m)-0.04(m)(m)

24 Apr 2026 ○ Estimate (m) ● Actual -1.30

-1.38-1.10-0.82-0.54-0.2626 Apr 2024: estimate (m); actual -0.4426 Apr 2024(m)25 Apr 2025: estimate (m); actual -0.8425 Apr 2025(m)24 Apr 2026: estimate (m); actual -1.3024 Apr 2026(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
26 Apr 202524 Apr 2026(m)-1.30(m)(m)
27 Apr 202425 Apr 2025(m)-0.84(m)(m)
29 Apr 202326 Apr 2024(m)-0.44(m)(m)

Revenue vs. Earnings

USD

31 Jul 2026 ■ Revenue 843.00M ■ Earnings 0.00M — Profit margin 0.00%

-234.44M-16.1%163.19M-10.4%560.81M-4.7%958.44M1.0%24 Jan 2025: revenue 687.00M; earnings -10.00M; profit margin -1.46%24 Jan 202525 Jul 2025: revenue 723.00M; earnings -19.00M; profit margin -2.63%25 Jul 202523 Jan 2026: revenue 790.00M; earnings -119.00M; profit margin -15.06%23 Jan 202631 Jul 2026: revenue 843.00M; earnings 0.00M; profit margin 0.00%31 Jul 2026

24 Apr 2026 ■ Revenue 3.10B ■ Earnings -0.33B — Profit margin -10.74%

-0.75B-11.7%0.67B-9.0%2.09B-6.3%3.51B-3.5%26 Apr 2024: revenue 2.47B; earnings -0.11B; profit margin -4.54%26 Apr 202425 Apr 2025: revenue 2.71B; earnings -0.21B; profit margin -7.85%25 Apr 202524 Apr 2026: revenue 3.10B; earnings -0.33B; profit margin -10.74%24 Apr 2026

Analyst insights

View more →
RatingsBuyHoldSellOther ratingsLast CloseAverage TargetUpsideHigh TargetLow Target
(m)(m)(m)(m)(m)$16.71(m)(m)(m)(m)
Past 12 Months12 Month ForecastLast Close$16.71High(m)Average(m)Low(m)2026-03-062026-11-06

Recent news

View more →

(m)

YouTube videos mentioning MMED

View more →

(m)

Statistics

View more →

Retained observations as of 2026-11-11; financial period ending 31 Jul 2026.

Forward P/E
(m)
PEG ratio · 5-year expected
(m)
Shares held by insiders
(m)
Insider transactions · change (%)
(m)
Shares held by institutions
(m)
Institutional transactions · change (%)
(m)
Diluted EPS · 12 month
(m)
EPS estimate · next quarter
(m)
EPS estimate · next year
(m)
EPS growth · current annual estimate
(m)
EPS growth · next annual estimate
(m)
EPS growth · next 5 years expected
(m)
EPS growth · past 3 years annualized
(m)
EPS growth · past 5 years annualized
(m)
EPS change · 12 months vs prior year
(m)
EPS change · latest quarter vs previous quarter
(m)
Latest earnings report date
(m)
EPS surprise · latest reported quarter
(m)
Net income · 12 month
$-314.00M
Profit margin
-9.75%
Return on assets · 12 month
(m)
Named executive and board stock awards · latest fiscal year
(m)
Index membership
(m)
Employees
(m)
IPO date
(m)
Options available
(m)
Shortable
(m)
Analyst recommendation
(m)
Analyst target price
(m)
Price volatility · week
(m)
Price volatility · month
(m)
Average true range · 14 sessions
(m)
Relative strength index · 14 sessions
(m)
Relative volume
(m)
Average daily volume
2.97M
Latest session volume
(m)
Last session value
(m)
30 days ago session value
(m)
1 year ago session value
(m)
Number of trades
(m)
Total return · week
-5.47%*
Total return · month
-0.30%*
Total return · quarter
34.68%*
Total return · half year
38.49%*
Total return · year to date
(m)
Total return · 1 year
(m)
Total return · 3 years
(m)
Total return · 5 years
(m)
Market cap
(m)
Book value per share · latest quarter
(m)
Price / cash · latest quarter
(m)
Enterprise value
(m)
Enterprise value / revenue
(m)
Enterprise value / EBITDA
(m)
Dividend · 12 months per share
(m)
Dividend ex-date
(m)
Next dividend ex-date
(m)
Next dividend amount per share
(m)
Dividend growth · 3 years annualized
(m)
Dividend growth · 5 years annualized
(m)
Revenue · 12 month
$3.22B
Revenue growth · past 3 years annualized
(m)
Revenue growth · past 5 years annualized
(m)
Revenue change · 12 months vs prior year
(m)
Revenue change · latest quarter vs previous quarter
(m)
Revenue surprise · latest reported quarter
(m)
Levered free cash flow · 12 month
(m)
Debt / equity · latest quarter
(m)
Long-term debt / equity · latest quarter
(m)
Return on equity · 12 month
(m)
Return on invested capital · 12 months
(m)
Previous close
(m)
Latest closing price
(m)
Latest session change (%)
(m)
52-week high
(m)
52-week low
(m)
Price vs 20-session moving average
(m)
Price vs 50-session moving average
(m)
Price vs 200-session moving average
(m)
Float shares
(m)
Short float (%)
(m)
Short ratio (days to cover)
(m)
Short interest (shares)
(m)

Five-year projected P/E and P/S repeat the preceding five-year EPS and revenue CAGR, holding current price and market cap constant. Hover a calculated row for its formula. Net assets = assets − debt − payables − deferred revenue − obligations due within 1 year − obligations due after 1 year.

Holders breakdown

View more →
BreakdownOwnership
(m)Shares held by all insiders
(m)Shares held by institutions
(m)Float held by institutions
(m)Institutions holding shares

Other holders

(m)

View more →

Insider holders

(m)

View more →

Top institutional holders

(m)

View more →

Top mutual fund holders

(m)

View more →

MiniMed Group, Inc. Overview

View more →

(m)

(m)

SEC CIK
2062583
Industry (SIC)
3841 Surgical & Medical Instruments & Apparatus
Country of operation
United States
Business address
18000 DEVONSHIRE ST., NORTHRIDGE, California, 91325, United States
Fiscal year end
1231
Phone
763-222-9423

Similar stocks

Stock NameCountryMarket CapPE Ratio
MERIT MEDICAL SYSTEMS INC (MMSI)United States$5.212B28.44
TELEFLEX INC (TFX)United States$5.093B-5.44
HAEMONETICS CORP (HAE)United States$4.821B36.52
Heartflow, Inc. (HTFL)United States$4.225B
ICU MEDICAL INC/DE (ICUI)United States$4.153B18.85
PULSE BIOSCIENCES, INC. (PLSE)United States$3.696B-24.47
iRhythm Holdings, Inc. (IRTC)United States$3.651B-281.06
AtriCure, Inc. (ATRC)United States$3.089B
GLAUKOS Corp (GKOS)United States$9.135B-43.73
UFP TECHNOLOGIES INC (UFPT)United States$2.308B28.37